Solving the Viral-Chemical Puzzle of Human Liver Carcinogenesis

Cancer Epidemiology Biomarkers and Prevention

Volumn 3, Issue 1, 1983, Pages 1-2

  Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; AFLATOXIN B; ALCOHOL; PROTEIN P53;

ALCOHOL CONSUMPTION; ASPERGILLUS FLAVUS; CHEMICAL CARCINOGENESIS; CHRONIC ACTIVE HEPATITIS; EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

AFLATOXIN B1; ALCOHOLISM; CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HUMAN; LIVER NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0028334311     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Beasley, R. P., Hwang, L. Y., Lin, C. C., and Chien, C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet, 2: 1129–1133, 1981.
2. Rogler, C. E., and Chisari, F. V. Cellular and molecular mechanisms of hepatocarcinogenesis. Semin. Liver Dis., 12: 265–278, 1992.
3. Fourel, G., Trepo, C., Bougueleret, L., Henglein, B., Ponzetto, A., Tiollais, P., and Buendia, M. A. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature (Lond.), 347: 294-298, 1990.
4. Matsubara, K., and Tokino, T. Integration of hepatitis B virus DNA and its implications to hepatocarcinogenesis. Mol. Biol. Med., 7: 243–260, 1990.
5. Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., and Kawashima, T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med., 328: 1797-1801, 1993.
6. Austin, H. The role of tobacco use and alcohol consumption in the etiology of hepatocellular carcinoma. In: Tabor, E., DiBisceglie, A. M., and Purcell, R. H. (eds.), Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Advances in Applied Biotechnology Series, pp. 57–77. The Woodlands, TX: Portfolio Publishing Co., 1991.
7. Wogan, G. N. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res., 52: 2114s—2118s, 1992.
8. Bulatao-Jayme, J., Almero, E. M., Castro, M. C., Jardeleza, M. T., and Salamat, L. A. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int. J. Epidemiol., 11: 112–119, 1982.
9. Peers, F., Bosch, X., Kaldor, J., Linsell, A., and Pluijmen, M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int. J. Cancer, 39: 545–553, 1987.
10. Van Rensburg, S. J., Cook-Mozaffari, P., Van Schalkwyk, D. J., Van der Watt, J. J., Vincent, T. J., and Purchase, I. F. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer, 51: 713–726, 1985.
11. Yeh, F. S., Yu, M. C., Mo, C. C., Luo, S., Tong, M. J., and Henderson, B. E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res., 49: 2506–2509, 1989.
12. Ross, R. K., Yuan, J. M., Yu, M. C., Wogan, G. N., Qian, G. S., Tu, J. T., Groopman, J. D., Gao, Y. T., and Henderson, B. E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339: 943-946, 1992.
13. Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., Wogan, G. N., and Groopman, J. D. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol., Biomarkers & Prev., 3: 3–10, 1993.
14. Pfeifer, A. M. A., Cole, K. E., Smoot, D. T., Weston, A., Groopman, J. D., Shields, P. G., Vignaud, J. M., Juillerat, M., Lipsky, M. M., Trump, B. F., Lechner, J. F., and Harris, C. C. SV40 T-antigen immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc. Natl. Acad. Sci. USA, 90: 5123–5127, 1993.
15. Autrup, H., Harris, C. C., Wu, S. M., Bao, L. Y., Pei, X. F., Lu, S., Sun, T. T., and Hsia, C. C. Activation of chemical carcinogens by cultured human fetal liver, esophagus and stomach. Chem. Biol. Interact., 50: 15-25, 1984.
16. Aoyama, T., Yamano, S., Guzelian, P. S., Gelboin, H. V., and Gonzalez, F. J. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome p450 metabolically activate aflatoxin B1. Proc. Natl. Acad. Sci. USA, 87: 4790-4793, 1990.
17. Harris, C. C., and Hollstein, M. C. Clinical implications of the p53 tumor suppressor gene. N. Engl. J. Med., 329: 1318-1327, 1993.